Development and validation of an interpretable machine learning model for diagnosing pathologic complete response in

Qi Zhou1, Fei Peng2, Zhiyuan Pang3

  • 1Department of Breast Surgery, Tangshan People's Hospital (Hebei Key Laboratory of Molecular Oncology, Affiliated Tangshan People's Hospital of North China University of Science and Technology), Tangshan, Hebei, China.

Summary

A new AI framework accurately identifies pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) in breast cancer patients. This tool helps determine if surgery can be safely omitted, improving patient outcomes.

Related Concept Videos